{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:39:50Z","timestamp":1782823190103,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.vaccine.2026.128571","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T12:43:51Z","timestamp":1776861831000},"page":"128571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Improving cholera vaccination impact through advances in gut mucosal immunology: outcomes of a 2025 expert consultation"],"prefix":"10.1016","volume":"81","author":[{"given":"Anna","family":"Lundgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Vannice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Holmgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10333","key":"10.1016\/j.vaccine.2026.128571_bb0005","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(22)00330-0","article-title":"Cholera","volume":"399","author":"Kanungo","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128571_bb0010","unstructured":"WHO. Cholera (Facts Sheet); 2024. https:\/\/wwwwhoint\/news-room\/fact-sheets\/detail\/cholera."},{"key":"10.1016\/j.vaccine.2026.128571_bb0015","unstructured":"WHO. Guidelines on clinical evaluation of vaccines: regulatory expectations, Annex 9, TRS No 1004; 2017. https:\/\/wwwwhoint\/publications\/m\/item\/clinical-evaluation-of-vaccines-annex-9-trs-no-1004."},{"issue":"2","key":"10.1016\/j.vaccine.2026.128571_bb0020","article-title":"An update on cholera immunity and current and future cholera vaccines","volume":"6","author":"Holmgren","year":"2021","journal-title":"Trop Med Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128571_bb0025","article-title":"Systemic, mucosal, and memory immune responses following cholera","volume":"6","author":"Ryan","year":"2021","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128571_bb0030","unstructured":"WHO. Ending Cholera\u2014A Global Roadmap to 2030; 2017. https:\/\/wwwgtfccorg\/about-gtfcc\/roadmap-2030."},{"issue":"12","key":"10.1016\/j.vaccine.2026.128571_bb0035","article-title":"Oral cholera vaccine efficacy and effectiveness","volume":"9","author":"Song","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128571_bb0040","doi-asserted-by":"crossref","first-page":"e1203","DOI":"10.1016\/S2214-109X(25)00107-X","article-title":"Protection from killed whole-cell cholera vaccines: a systematic review and meta-analysis","volume":"13","author":"Xu","year":"2025","journal-title":"Lancet Glob Health"},{"issue":"9479","key":"10.1016\/j.vaccine.2026.128571_bb0045","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(05)66550-6","article-title":"Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis","volume":"366","author":"Ali","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128571_bb0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/inthealth\/ihy085","article-title":"Herd protection of unvaccinated adults by oral cholera vaccines in rural Bangladesh","volume":"11","author":"Ali","year":"2019","journal-title":"Int Health"},{"key":"10.1016\/j.vaccine.2026.128571_bb0055","author":"WHO"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128571_bb0060","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S1473-3099(23)00742-9","article-title":"Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: a matched case-control study","volume":"24","author":"Malembaka","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128571_bb0065","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41591-024-02810-4","article-title":"Clinical surveillance systems obscure the true cholera infection burden in an endemic region","volume":"30","author":"Hegde","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2026.128571_bb0070","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268824000888","article-title":"Inferring the proportion of undetected cholera infections from serological and clinical surveillance in an immunologically naive population","volume":"152","author":"Finger","year":"2024","journal-title":"Epidemiol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128571_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2024.100981","article-title":"Protection by natural cholera against later episodes of cholera over 10 years of follow-up in Matlab, Bangladesh: a retrospective cohort study","volume":"6","author":"Hoque","year":"2025","journal-title":"The Lancet Microbe"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128571_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040336","article-title":"Controlling endemic cholera with oral vaccines","volume":"4","author":"Longini","year":"2007","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128571_bb0085","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02235-25","article-title":"Human antibody targeting Vibrio cholerae O1 O-specific polysaccharide induces an amotile hypovirulent bacterial phenotype: mechanism of protection against cholera","volume":"16","author":"Verma","year":"2025","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128571_bb0090","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02847-20","article-title":"Humans surviving cholera develop antibodies against vibrio cholerae O-specific polysaccharide that inhibit pathogen motility","volume":"11","author":"Charles","year":"2020","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128571_bb0095","doi-asserted-by":"crossref","first-page":"e0006376","DOI":"10.1371\/journal.pntd.0006376","article-title":"Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae o1 el tor inaba in north American volunteers","volume":"12","author":"Islam","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128571_bb0100","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/CVI.00196-12","article-title":"Antigen-specific memory t cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired cholera","volume":"19","author":"Arifuzzaman","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128571_bb0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.it.2024.01.006","article-title":"Gut-associated lymphoid tissue: a microbiota-driven hub of b cell immunity","volume":"45","author":"Bemark","year":"2024","journal-title":"Trends Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128571_bb0110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.mucimm.2024.03.004","article-title":"Migratory CD103(+)CD11b(+) cDC2s in Peyer\u2019s patches are critical for gut IgA responses following oral immunization","volume":"17","author":"Gribonika","year":"2024","journal-title":"Mucosal Immunol"},{"issue":"73","key":"10.1016\/j.vaccine.2026.128571_bb0115","doi-asserted-by":"crossref","first-page":"eabc5500","DOI":"10.1126\/sciimmunol.abc5500","article-title":"Peyer\u2019s patch T(H)17 cells are dispensable for gut IgA responses to oral immunization","volume":"7","author":"Gribonika","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.vaccine.2026.128571_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12698","article-title":"Limited clonal relatedness between gut IgA plasma cells and memory b cells after oral immunization","volume":"7","author":"Bemark","year":"2016","journal-title":"Nat Commun"},{"issue":"12 Suppl 2","key":"10.1016\/j.vaccine.2026.128571_bb0125","doi-asserted-by":"crossref","first-page":"S742","DOI":"10.1093\/infdis\/jiab423","article-title":"Modern history of cholera vaccines and the pivotal role of icddr,b","volume":"224","author":"Holmgren","year":"2021","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128571_bb0130","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/infdis\/149.6.884","article-title":"Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined b subunit-whole cell vaccine","volume":"149","author":"Svennerholm","year":"1984","journal-title":"J Infect Dis"},{"issue":"30","key":"10.1016\/j.vaccine.2026.128571_bb0135","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/j.vaccine.2013.04.066","article-title":"Different kinetics of circulating antibody-secreting cell responses after primary and booster oral immunizations: a tool for assessing immunological memory","volume":"31","author":"Leach","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128571_bb0140","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.vaccine.2016.11.055","article-title":"Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic country","volume":"35","author":"Akhtar","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128571_bb0145","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S1473-3099(19)30571-7","article-title":"Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1\/2 trial","volume":"20","author":"Qadri","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128571_bb0150","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.vaccine.2008.12.036","article-title":"Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding","volume":"27","author":"Ahmed","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128571_bb0155","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1172\/JCI115270","article-title":"Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory","volume":"88","author":"Quiding","year":"1991","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128571_bb0160","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02021-16","article-title":"Single-cell analysis of the plasmablast response to vibrio cholerae demonstrates expansion of cross-reactive memory b cells","volume":"7","author":"Kauffman","year":"2016","journal-title":"mBio"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128571_bb0165","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03679-20","article-title":"Impact of immunoglobulin isotype and epitope on the functional properties of Vibrio cholerae O-specific polysaccharide-specific monoclonal antibodies","volume":"12","author":"Kauffman","year":"2021","journal-title":"mBio"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128571_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009743","article-title":"Longitudinal analysis of human humoral responses after vaccination with a live attenuated v. cholerae vaccine","volume":"15","author":"Adekunle","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128571_bb0175","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.immuni.2024.03.015","article-title":"Vaccine adjuvants: tailoring innate recognition to send the right message","volume":"57","author":"Lavelle","year":"2024","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128571_bb0180","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/s41385-019-0159-z","article-title":"Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines","volume":"12","author":"Davitt","year":"2019","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2026.128571_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102398","article-title":"Recent advances in enterotoxin vaccine adjuvants","volume":"85","author":"Crothers","year":"2023","journal-title":"Curr Opin Immunol"},{"issue":"52","key":"10.1016\/j.vaccine.2026.128571_bb0190","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1016\/j.vaccine.2014.10.069","article-title":"Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled phase i study","volume":"32","author":"Lundgren","year":"2014","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2026.128571_bb0195","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.vaccine.2019.02.025","article-title":"Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge","volume":"37","author":"Harro","year":"2019","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128571_bb0200","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00539-22","article-title":"Nontoxigenic Vibrio cholerae challenge strains for evaluating vaccine efficacy and inferring mechanisms of protection","volume":"13","author":"Fakoya","year":"2022","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128571_bb0205","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0022-1759(88)90086-5","article-title":"A method of obtaining, processing, and analyzing human intestinal secretions for antibody content","volume":"110","author":"Gaspari","year":"1988","journal-title":"J Immunol Methods"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128571_bb0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1084\/jem.20161590","article-title":"Antibody-secreting plasma cells persist for decades in human intestine","volume":"214","author":"Landsverk","year":"2017","journal-title":"J Exp Med"},{"issue":"7768","key":"10.1016\/j.vaccine.2026.128571_bib236","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41586-019-1453-3","article-title":"Cholera toxin promotes pathogen acquisition of host-derived nutrients","volume":"572","author":"Rivera-Ch\u00e1vez","year":"2019","journal-title":"Nature."},{"issue":"10","key":"10.1016\/j.vaccine.2026.128571_bb0215","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1128\/CVI.00347-13","article-title":"Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh","volume":"20","author":"Rahman","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128571_bb0220","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/oxfordjournals.aje.a115515","article-title":"Breast feeding and the risk of severe cholera in rural Bangladeshi children","volume":"131","author":"Clemens","year":"1990","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128571_bb0225","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/cid\/ciac782","article-title":"Co-administration of oral cholera vaccine with oral polio vaccine among Bangladeshi young children: a randomized controlled open label trial to assess interference","volume":"76","author":"Islam","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"8499","key":"10.1016\/j.vaccine.2026.128571_bb0230","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(86)91944-6","article-title":"Field trial of oral cholera vaccines in Bangladesh","volume":"2","author":"Clemens","year":"1986","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128571_bb0235","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/infdis\/158.2.372","article-title":"Cross-protection by b subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial","volume":"158","author":"Clemens","year":"1988","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26003798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26003798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:48:31Z","timestamp":1778737711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26003798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":48,"alternative-id":["S0264410X26003798"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128571","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving cholera vaccination impact through advances in gut mucosal immunology: outcomes of a 2025 expert consultation","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128571"}}